GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMO) » Definitions » Cyclically Adjusted PB Ratio

Avid Bioservices (Avid Bioservices) Cyclically Adjusted PB Ratio : 4.87 (As of May. 15, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Avid Bioservices Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Avid Bioservices's current share price is $9.20. Avid Bioservices's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 was $1.89. Avid Bioservices's Cyclically Adjusted PB Ratio for today is 4.87.

The historical rank and industry rank for Avid Bioservices's Cyclically Adjusted PB Ratio or its related term are showing as below:

CDMO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.05   Med: 4.06   Max: 23.74
Current: 4.67

During the past years, Avid Bioservices's highest Cyclically Adjusted PB Ratio was 23.74. The lowest was 1.05. And the median was 4.06.

CDMO's Cyclically Adjusted PB Ratio is ranked worse than
76.98% of 643 companies
in the Biotechnology industry
Industry Median: 1.78 vs CDMO: 4.67

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Avid Bioservices's adjusted book value per share data for the three months ended in Jan. 2024 was $2.839. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.89 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avid Bioservices Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Avid Bioservices's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Cyclically Adjusted PB Ratio Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.18 4.25 15.15 8.73 9.93

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.02 9.93 6.81 3.25 3.59

Competitive Comparison of Avid Bioservices's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Avid Bioservices's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Cyclically Adjusted PB Ratio falls into.



Avid Bioservices Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Avid Bioservices's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=9.20/1.89
=4.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avid Bioservices's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Avid Bioservices's adjusted Book Value per Share data for the three months ended in Jan. 2024 was:

Adj_Book=Book Value per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=2.839/129.4194*129.4194
=2.839

Current CPI (Jan. 2024) = 129.4194.

Avid Bioservices Quarterly Data

Book Value per Share CPI Adj_Book
201404 2.649 100.023 3.428
201407 2.562 100.520 3.299
201410 2.261 100.176 2.921
201501 1.892 98.604 2.483
201504 2.137 99.824 2.771
201507 1.931 100.691 2.482
201510 2.146 100.346 2.768
201601 1.806 99.957 2.338
201604 1.479 100.947 1.896
201607 1.187 101.524 1.513
201610 1.173 101.988 1.488
201701 1.033 102.456 1.305
201704 1.217 103.167 1.527
201707 1.242 103.278 1.556
201710 0.950 104.070 1.181
201801 0.696 104.578 0.861
201804 1.001 105.708 1.226
201807 1.013 106.324 1.233
201810 0.977 106.695 1.185
201901 0.946 106.200 1.153
201904 0.945 107.818 1.134
201907 0.883 108.250 1.056
201910 0.873 108.577 1.041
202001 0.834 108.841 0.992
202004 0.742 108.173 0.888
202007 0.822 109.318 0.973
202010 0.871 109.861 1.026
202101 1.403 110.364 1.645
202104 1.273 112.673 1.462
202107 0.728 115.183 0.818
202110 0.830 116.696 0.920
202201 0.917 118.619 1.000
202204 2.824 121.978 2.996
202207 2.879 125.002 2.981
202210 2.908 125.734 2.993
202301 2.965 126.223 3.040
202304 3.022 127.992 3.056
202307 3.020 128.974 3.030
202310 2.905 129.810 2.896
202401 2.839 129.419 2.839

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avid Bioservices  (NAS:CDMO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Avid Bioservices Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (Avid Bioservices) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Executives
Matthew R. Kwietniak officer: Chief Commercial Officer 14191 MYFORD ROAD, TUSTIN CA 92780
Richard A. Richieri officer: Chief Operations Officer 14191 MYFORD ROAD, TUSTIN CA 92780
Daniel Ryan Hart officer: Chief Financial Officer 2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780
Mark R Ziebell officer: V.P., General Counsel 14282 FRANKLIN AVENUE, TUSTIN CA 92780
Richard B Hancock director 14282 FRANKLIN AVE., TUSTIN CA 92780
Joseph Carleone director 3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169
Nicholas Stewart Green director, officer: President & CEO 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Gregory Sargen director
Esther M. Alegria director 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Mark R Bamforth director 500 KENDALL ST., CAMBRIDGE MA 02142
Jeanne Thoma director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
Catherine J Mackey director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Joel Mccomb director 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
Stephen Michael Hedberg officer: Principal Fin. & Acct. Officer 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780

Avid Bioservices (Avid Bioservices) Headlines